INVASCENT
InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III (ILSF-III). These funds provide private equity growth capital to companies in the Indian pharmaceutical, healthcare, animal health and medtech industries. Examples of funds usage include capacity expansion, introduction of new products, acquisitions, etc. The typical investment size is in the range of USD 10 - 40 million over the life of the investment for a significant minority stake.
INVASCENT
Industry:
Health Care Pharmaceutical
Status:
Active
Contact:
040 2354 1305
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible SPF Google Font API LetsEncrypt Apple Mobile Web Clips Icon Content Delivery Network Font Awesome Apache Euro
Similar Organizations
1315 Capital
1315 Capital provides expansion and growth capital to commercial stage pharmaceuticals, medical technologies, and healthcare services.
Rittenhouse Ventures
Rittenhouse Ventures invests in small rounds of capital-efficient Early-Growth stage companies primarily in Healthcare and Pharma IT.
Tivorsan Pharmaceuticals
Tivorsan Pharmaceuticals is a protein therapeutics company that focuses on treating neuromuscular disorders.
Current Employees Featured
Founder
Investments List
| Date | Company | Article | Money raised |
|---|---|---|---|
| 2022-06-02 | Accumax | InvAscent investment in Private Equity Round - Accumax | 5.2 B INR |
| 2022-04-25 | Malladi Drugs | InvAscent investment in Private Equity Round - Malladi Drugs | 2.5 B INR |
| 2021-02-02 | MediBuddy | InvAscent investment in Series B - MediBuddy | 40 M USD |
| 2020-06-16 | Murli Krishna Pharma | InvAscent investment in Private Equity Round - Murli Krishna Pharma | 700 M INR |
| 2020-06-08 | Sharp Sight | InvAscent investment in Private Equity Round - Sharp Sight | 700 M INR |
| 2019-01-01 | Intron Life Sciences | InvAscent investment in Private Equity Round - Intron Life Sciences | 10 M USD |
| 2018-10-31 | Strides Pharma Science | InvAscent investment in Post-IPO Equity - Strides Pharma Science | 20 M USD |
| 2017-03-15 | Oliva Clinic | InvAscent investment in Series A - Oliva Clinic | 832 K USD |
| 2016-12-01 | Stericon Pharma | InvAscent investment in Private Equity Round - Stericon Pharma | 500 M INR |
| 2016-01-08 | Sandor | InvAscent investment in Seed Round - Sandor | 8.98 M USD |
More informations about "InvAscent"
About Us – InvAscent
InvAscent has a successful track record of partnering with entrepreneurs in the Indian pharma, healthcare delivery, medtech, and animal health industries, enabling creation of market leaders.See details»
InvAscent - Crunchbase Investor Profile & Investments
InvAscent is a private equity growth capital for pharma, healthcare, animal health, and medtech businesses in India.See details»
InvAscent - LinkedIn
InvAscent | 2,309 followers on LinkedIn. Healthcare Private Equity | InvAscent is the investment advisor to EILSF (Fund I), India Life Sciences Fund II (ILSF-II) and India Life Sciences Fund III …See details»
InvAscent - 2025 Investor Profile & Team - Tracxn
Jun 19, 2025 InvAscent is a private equity firm founded in 2006. It is primarily based in Hyderabad, India. As of Jun 2025, InvAscent is an active investor with a portfolio of 40 compan ies, comprising 40 funding round s and 1 acquisition. In …See details»
InvAscent Portfolio Investments, InvAscent Funds, InvAscent Exits
Nov 22, 2023 About InvAscent InvAscent is the investment advisor to EILSF and India Life Sciences Fund II who provide private equity growth capital to companies in the Indian …See details»
Interview with Hari Buggana - ifc.org
Mar 31, 2025 Discover why the global healthcare market relies on generics in our interview with Hari Buggana, Founder of InvAscent. Learn about the challenges and strategies for India's healthcare system.See details»
InvAscent investment portfolio | PitchBook
InvAscent Investments (49) InvAscent’s most recent investment was a with SRV Hospitals for . The deal was made on 17-Apr-2025 with as the lead partner.See details»
InvAscent
Plot No. 1174A, Road No. 56, Jubilee Hills, Hyderabad, Telangana, India – 500033 Tel: +91 (40) 23541305 Email: [email protected]See details»
PE firm InvAscent keen to list five portfolio companies
Jan 3, 2024 Private equity firm InvAscent plans to list five portfolio companies in the health and pharmaceutical sectors over the next 24–36 months, providing exit opportunities for the investor.See details»
Team – InvAscent
200+ years of collective experience across pharma, healthcare, private equity, investment banking, consulting, and corporate financeSee details»
InvAscent - Investments, Portfolio & Company Exits - Crunchbase
InvAscent is a private equity growth capital for pharma, healthcare, animal health, and medtech businesses in India.See details»
InvAscent invests ₹110 crore in Geri Care | Geri Care
Jan 27, 2025 Nithya Govind, Managing Director, InvAscent said, “Geri Care is a pioneer in creating an innovative continuum care model, redefining eldercare in India. We are very …See details»
InvAscent leads $13 Mn round in Geri Care Health Services
Jan 27, 2025 Geri Care Health Services, an integrated senior citizen-focused healthcare services provider, has raised Rs 110 crore ($13 million) in a funding round led by InvAscent, …See details»
Portfolio – InvAscent
Leveraging domain insights and operational experience, generated over 4-fold increase in EBITDA across portfolio companiesSee details»
InvAscent crosses halfway mark for new healthcare fund, eyes
Jun 26, 2024 Healthcare-focused private equity firm InvAscent, which has already struck three bets so far this year, is set to mark the final close of its latest domestic vehicle with a slightly …See details»
Press Releases – InvAscent
Jan 27, 2025 InvAscent invests in Maiva Pharma May 2, 2024 InvAscent, through India Life Sciences IV (ILSF IV), in partnership Morgan Stanley Private Equity Asia, has invested INR …See details»
InvAscent - Contacts, Employees, Board Members, Advisors
InvAscent is a private equity growth capital for pharma, healthcare, animal health, and medtech businesses in India.See details»
InvAscent invests in Maiva Pharma
May 2, 2024 InvAscent invests in Maiva Pharma May 2, 2024 InvAscent, through India Life Sciences IV (ILSF IV), in partnership Morgan Stanley Private Equity Asia, has invested INR …See details»
Morgan Stanley, InvAscent invest Rs.1,000-Cr in CDMO Maiva …
Private Equity PE Fund Investments Morgan Stanley, InvAscent invest Rs.1,000-Cr in CDMO Maiva Pharma for controlling stake Times of India Maiva Pharma , a Benguluru-based pure …See details»
Board of Directors | Aizant Drug Research Solutions Pvt Ltd
Here at Aizant, our board of directors brings a wealth of experience, leadership, and strategic insight to help drive the company’s vision and mission. Our board members play a key role in …See details»